LivaNova PLC (LIVN) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation.

Total Assets Chart for LivaNova PLC

LivaNova PLC (LIVN) total assets for FY2025 were USD 2.6B, a 4.0% change from FY2024. LivaNova PLC's total assets grew from USD 25.2M in 1992 to USD 2.6B in 2025 (10241.7% over 33 years). Total assets compound annual growth rate: 5-year CAGR of 1.7%, 10-year CAGR of 0.2%, 20-year CAGR of 15.3%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$4.12B
Implied Share Price
$74.93
Enterprise Value
$4.09B
Revenue (TTM)
$1.47B
EBITDA
$260.14M
Profit Margin
12.81%
Trailing P/E
22.17
Forward P/E
16.00
Price/Book (MRQ)
3.23
Price/Sales (TTM)
2.80
EV/EBITDA
20.03
EV/Revenue
2.80
Dividend Yield
—
Book Value
$24.07
Free Cash Flow (FY2025)
$173.20M
Free Cash Flow Yield
4.21%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.